Search Results 61-70 of 15726 for Carrie Thompson

  1. Non-Hodgkin lymphoma - Doctors and departments - Mayo Clinic

    Carrie A. Thompson, M.D.. Hematologist. Rochester, MN. Areas of focus: Cancer survivorship program, B-cell lymphoma, Non-Hodgkin ...

  2. Hematology - Doctors - Mayo Clinic

    Carrie A. Thompson, M.D.. Hematologist. Rochester, MN. Areas of focus: Cancer survivorship program, B-cell lymphoma, Non-Hodgkin ...

  3. Hematology - Doctors - Mayo Clinic

    Gita Thanarajasingam, M.D.. Internist; Oncologist; Hematologist. Rochester, MN. Carrie A. Thompson, M.D.. Hematologist. Rochester, MN ...

  4. Lymphoma - Doctors and departments - Mayo Clinic

    Carrie A. Thompson, M.D.. Hematologist. Rochester, MN. Areas of focus: Cancer survivorship program, Non-Hodgkin lymphoma, Hodgkin ...

  5. Internal Medicine Preliminary Residency (Minnesota) - Curriculum

    Carrie Thompson, M.D., M.S.. Program Director. Education Coordinator Phone: 507-284-5934. Email: Res-IM@mayo.edu. Close. Academics ▸ Residencies and ...

  6. Hodgkin lymphoma (Hodgkin disease) - Doctors and departments - Mayo Clinic

    Carrie A. Thompson, M.D.. Hematologist. Rochester, MN. Areas of focus: Cancer survivorship program, Non ...

  7. Lymphoma - Doctors and departments - Mayo Clinic

    Carrie A. Thompson, M.D.. Hematologist. Rochester, MN. Areas of focus: Cancer survivorship program, Non-Hodgkin lymphoma, Hodgkin ...

  8. E Aubrey Thompson, Ph.D. - Mayo Clinic Faculty Profiles

    E. Aubrey Thompson, Ph.D., is a cancer biology researcher at Mayo Clinic who studies single-cell spatial RNA, immunotherapy and breast cancer.

  9. Lymphoma - Doctors and departments - Mayo Clinic

    Carrie A. Thompson, M.D.. Hematologist. Rochester, MN. Areas of focus: Cancer survivorship program, B-cell lymphoma, Non-Hodgkin ...

  10. Mayo Clinic: Imaging Scans Provide Little Help Detecting Relapse of Aggressive Lymphoma

    ... Carrie Thompson, M.D., a Mayo Clinic hematologist. "We found that scans ... Thompson and her colleagues looked at patients in remission to identify how ...